Fenneridone is a new type of mineralocorticoid receptor antagonist, which can delay the progression of chronic kidney disease. Some people may be aware of two other mineralocorticoid receptor antagonists: diuretics, antihypertensive drugs, spironolactone, and eplerenone. Non neridone is their sibling, and the third generation of mineralocorticoid receptor antagonist just came out after them.